Navigation Links
Death rate from tuberculosis in homeless alarmingly high: Study
Date:2/16/2011

TORONTO, Ont., February 16, 2011 One in five homeless people with tuberculosis die within a year of their diagnosis, according to a study led by St. Michael's Hospital's Dr. Kamran Khan. And that number remains unchanged over the last decade despite recommendations calling for greater improvements in prevention and control of tuberculosis in homeless shelters.

A provincial coroner's inquest into the death of Joseph Teigesser, a homeless man who died of tuberculosis in Toronto in 2001, made 13 formal recommendations. These included provincial funding for a centralized clinic system to provide specialized care for those with tuberculosis in Ontario and a review and improvement of shelter ventilation systems. However, the work surrounding these two key recommendations has fallen short, the researchers say in the study.

"The treatment of tuberculosis is often complicated by inadequate housing, substance dependence, language barriers, mental health problems, not to mention the enormous stigma that comes with this disease," Khan says. "To effectively control tuberculosis, centres with specialized expertise and resources are needed to address these complex issues."

The 10-year study, published in the March issue of the journal Emerging Infectious Diseases, also found a growing proportion of tuberculosis cases in Toronto's homeless shelters are in immigrants, raising the risk that dangerous drug resistant strains of tuberculosis could enter the shelter system.

The study found nearly 40 per cent of all tuberculosis cases in the homeless were in immigrants. About 56 per cent of all infections in immigrants involved strains that were not known to be circulating in the city, and were likely acquired in other parts of the world where drug resistance is common.

Historically, tuberculosis in Toronto's homeless population was mostly a disease of Canadian-born men. While highly drug resistant tuberculosis is unusual among people born in Canada, it is an emerging threat in many developing areas of the world. If a drug resistant strain of tuberculosis were introduced into the shelter system, it could set off an outbreak that would have serious public health implications and be very difficult to control. Financial resources to manage such an outbreak would dwarf the costs of strengthening preventive measures today, the researchers warn.

"There's been a lot of good work on tuberculosis prevention and treatment in the homeless sector in Toronto over the last several years, and ventilation systems in shelters have improved, although dedicated funds are needed to make further improvements," said Dr. Elizabeth Rea, a study co-author and associate medical officer of health with Toronto Public Health. "But we also need more affordable housing and we need better access to primary and specialized care for vulnerable homeless individuals."

Tuberculosis is a serious, contagious disease caused by a bacterial infection. Once a person is exposed to tuberculosis, the infection can remain dormant for years to decades before becoming active. However, persons with weakened immune systems, including many homeless persons, are at much greater risk of developing the active form of tuberculosis. While most tuberculosis cases are treatable, highly drug resistant strains of tuberculosis can be life threatening and require years of treatment to cure.

"We need to do a much better job in preventing tuberculosis from spreading in this vulnerable population, and in providing timely, effective clinical care for those who are affected by this disease," says Dr. Michael Gardam, co-author and director of the tuberculosis clinic at the Toronto Western Hospital. "We have shown in previous research that treatment in dedicated tuberculosis clinics by experienced staff plays a major role in improving the likelihood of survival from tuberculosis."


'/>"/>

Contact: Julie Saccone
sacconej@smh.ca
416-864-5047
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. Parenting after the death of a child a difficult balancing act: York U study
2. Healthy patients at high risk of cardiac death identified
3. New online tool predicts probability of death from stroke
4. Researchers identify the genotype of disorders causing cardiac sudden death syndrome
5. Researchers predict nearly 1.3 million cancer deaths in Europe in 2011
6. Anthropologist: Body Worlds visitors confront bodies but not death
7. Video Suggests Mother Chimps May Grieve Death of an Infant
8. The death switch in sepsis also promotes survival
9. Safety checklist use yields 10 percent drop in hospital deaths
10. Super Bowl losses can increase cardiac death
11. Victor Chang scientists unlock the gates on sudden cardiac death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: